European Journal of Internal Medicine
Volume 19, Issue 1 , Pages 60-62 , January 2008

Unexpected metastatic pheochromocytoma — An unusual presentation

  • Tanja Birrenbach

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
    • ,
  • Zeno Stanga

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
    • ,
  • Philippe Cottagnoud

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
    • ,
  • Armin Stucki

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
    • Pneumology, Berner Rehabilitation Center, Heiligenschwendi, Switzerland
    • Corresponding Author InformationCorresponding author. FMH Internal, Respiratory and Intensive Care Medicine, Policlinic and Clinic for Internal Medicine, University Hospital Bern, Freiburgstrasse 10, 3010 Bern, Switzerland. Tel.: +41 31 632 05 24; fax: +41 31 382 43 60.

Received 24 October 2006 ,Accepted 15 February 2007.

References 

  1. Shen WT, Sturgeon C, Clark OH, Duh Q-Y, Kebebew E. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery. 2004;136:1129–1137
  2. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted?. Urology. 1999;53:679–683
  3. Lucon AM, Pereira MAA, Mendonca BB, Halpern A, Wajchenbeg BL, Arap S. Pheochromocytoma: study of 50 cases. J Urol. 1997;157:1208–1212
  4. Glodny B, Winde G, Herwig R, et al. Clinical differences between benign and malignant pheochromocytomas. Endocr J. 2001;48:151–159
  5. Van der Harst E, de Herder W, de Krijger R, et al. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol. 2002;147:85–94
  6. Kaltsas G, Korbonits M, Heintz J, et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab. 2001;86:895–902

PII: S0953-6205(07)00170-7

doi: 10.1016/j.ejim.2007.02.029

European Journal of Internal Medicine
Volume 19, Issue 1 , Pages 60-62 , January 2008

Article Tools

* Image Usage & Resolution